Human CD8 T cells specific for the immunodominant HLA (human leukocyte antigen)–A*02:01–restricted melanoma antigen recognized by T-cells (MART-1) peptide ELAGIGILTV (35) were first generated by ex vivo stimulation of T cells from an HLA-A*02:01 human donor with autologous monocytic-derived dendritic cells (mDCs) presenting the MART-1 peptide. Here, CD8A is linked to melanoma.